1887
Surveillance Open Access
Like 0

Abstract

BACKGROUND

To enhance antibiotic stewardship and effectively address antimicrobial resistance (AMR), better understanding of subnational antibiotic consumption patterns is essential.

AIM

We aimed to assess antibiotic consumption in Germany using data from 2022 and integrated from two surveillance systems, focusing on regional differences by examining non-university acute care hospitals.

METHODS

We used pharmacy dispensing data from 525 regional or local hospitals and 35 university hospitals, covering 46.5 million patient days (PD), nearly half of all occupied bed days nationwide, to calculate antibiotic use densities (AUD) for systemic antibiotics, expressed as World Health Organization (WHO) ATC/DDD (Anatomical Therapeutic Chemical/Defined Daily Dose) per 100 patient days (DDD/100 PD). The analysis primarily focused on consumption patterns in non-university hospitals, assessing key antibiotic groups through mixed-effects regression. For sensitivity analyses, we employed hospital-adapted daily dose definitions.

RESULTS

Pooled AUD for participating non-university hospitals was 51.8 DDD/100 PD, with aminopenicillins/beta-lactamase inhibitors being the most prescribed group. Regression analyses, adjusted for hospital size and ward type/admitting specialty, indicated notable regional variation. We identified statistically significant differences in antibiotic consumption, particularly for beta-lactam antibiotics, fluoroquinolones and tetracyclines. For example, several regions exhibited up to 1.4-fold higher use of first- and second-generation cephalosporins compared with the western reference region.

CONCLUSION

This study highlights substantial regional variation in antibiotic use in German acute care hospitals, underlining the importance of further investigation into influencing factors such as regional guidelines and resistance rates. The methodological approach applied here may serve as a model for other countries interested in analysing regional differences in antibiotic consumption.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2025.30.45.2500560
2025-11-13
2026-04-18
/content/10.2807/1560-7917.ES.2025.30.45.2500560
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/30/45/eurosurv-30-45-4.html?itemId=/content/10.2807/1560-7917.ES.2025.30.45.2500560&mimeType=html&fmt=ahah

References

  1. Naghavi M, Vollset SE, Ikuta KS, Swetschinski LR, Gray AP, Wool EE, et al. Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050. Lancet. 2024;404(10459):1199-226.  https://doi.org/10.1016/S0140-6736(24)01867-1  PMID: 39299261 
  2. World Health Organization (WHO). WHO AWaRe (Access, Watch, Reserve) classification of antibiotics for evaluation and monitoring of use. Geneva: WHO; 2023. Available from: https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2023.04
  3. European Centre for Disease Prevention and Control (ECDC). Reducing antimicrobial resistance: is the EU progressing? Stockholm: ECDC; 2023. Available from: https://www.ecdc.europa.eu/en/news-events/eaad-2023-launch
  4. Bundesministerium für Gesundheit. DART 2030 – Deutsche Antibiotika-Resistenzstrategie 2023. [DART 2030 - German Antibiotic Resistance Strategy]. Berlin: BMG; 2023. German. Available from: https://www.bundesgesundheitsministerium.de/themen/praevention/antibiotika-resistenzen/dart-2030.html
  5. Scholle O, Asendorf M, Buck C, Grill S, Jones C, Kollhorst B, et al. Regional variations in outpatient antibiotic prescribing in Germany: a small area analysis based on claims data. Antibiotics (Basel). 2022;11(7):836.  https://doi.org/10.3390/antibiotics11070836  PMID: 35884090 
  6. Sante Publique France. Surveillance de la consommation des antibiotiques et des résistances bactériennes en établissement de santé. Mission Spares. Résultats 2023. [Surveillance of Antibiotic Consumption and Bacterial Resistance in Healthcare Settings: SPARES Mission - 2023 Results]. Saint-Maurice: Santé publique France; 2024. French. Available from: https://www.santepubliquefrance.fr/maladies-et-traumatismes/infections-associees-aux-soins-et-resistance-aux-antibiotiques/resistance-aux-antibiotiques/documents/rapport-synthese/surveillance-de-la-consommation-des-antibiotiques-et-des-resistances-bacteriennes-en-etablissement-de-sante.-mission-spares.-resultats-2023
  7. Osservatorio Nazionale sull’impiego dei Medicinali. L’uso degli antibiotici in Italia. Rapporto Nazionale 2022. [National Observatory on the Use of Medicines. Antibiotic Use in Italy. National Report 2022]. Roma: Agenzia Italiana del Farmaco; 2024. Italian. Available from: https://www.aifa.gov.it/documents/20142/2444801/Rapporto_Antibiotici_2022.pdf
  8. Goodman KE, Cosgrove SE, Pineles L, Magder LS, Anderson DJ, Dodds Ashley E, et al. Significant regional differences in antibiotic use across 576 US hospitals and 11 701 326 adult admissions, 2016-2017. Clin Infect Dis. 2021;73(2):213-22.  https://doi.org/10.1093/cid/ciaa570  PMID: 32421195 
  9. Degen H. Ausgangslage der Krankenhausplanung in den Bundesländern. [Current status of hospital planning in the federal states of Germany. Hospital Report 2024 – Structural Reform]. In: Klauber J, Wasem J, Beivers A, et al. (Eds) Krankenhaus-Report 2024 – Strukturreform. 2024. German.
  10. Robert Koch-Institut (RKI). AMR Surveillance. Berlin: RKI; 2025. Available from: https://amr.rki.de/Content/AVS/Main.aspx
  11. University Medical Center Freiburg. Abteilung für Infektiologie. ADKA-If-DGI. Antiinfektiva Surveillance 2025. [Department of Infectiology. Anti-Infective Surveillance 2025]. Freiburg: ADKA-If-DGI; 2025. German. Available from: https://www.antiinfektiva-surveillance.de/projekt/
  12. Schweickert B, Feig M, Schneider M, Willrich N, Behnke M, Peña Diaz LA, et al. Antibiotic consumption in Germany: first data of a newly implemented web-based tool for local and national surveillance. J Antimicrob Chemother. 2018;73(12):3505-15.  https://doi.org/10.1093/jac/dky345  PMID: 30239728 
  13. Eurostat. Healthcare resource statistics - beds 2024. Luxembourg: Eurostat. [Accessed: 17 Jun 2025]. Available from: https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Healthcare_resource_statistics_-_beds
  14. Norwegian Institute of Public Health. ATC/DDD Index 2024. Oslo: Norwegian Institute of Public Health. [Accessed: 8 May 2025]. Available from: https://atcddd.fhi.no/atc_ddd_index/
  15. Först G, de With K, Weber N, Borde J, Querbach C, Kleideiter J, et al. Validation of adapted daily dose definitions for hospital antibacterial drug use evaluation: a multicentre study. J Antimicrob Chemother. 2017;72(10):2931-7.  https://doi.org/10.1093/jac/dkx244  PMID: 29091214 
  16. Stroup WW, Ptukhina M, Garai J. Generalized linear mixed models: modern concepts, methods and applications: Chapman and Hall/CRC; 2024.  https://doi.org/10.1080/01621459.2025.2506201 
  17. Hothorn T, Bretz F, Westfall P. Simultaneous inference in general parametric models. Biom J. 2008;50(3):346-63.  https://doi.org/10.1002/bimj.200810425  PMID: 18481363 
  18. McGillycuddy M, Popovic G, Bolker BM, Warton DI. Parsimoniously fitting large multivariate random effects in glmmTMB. J Stat Softw. 2025;112(1):1-19.  https://doi.org/10.18637/jss.v112.i01 
  19. European Centre for Disease Prevention and Control (ECDC). Antimicrobial consumption in the EU/EEA (ESAC-Net) - Annual Epidemiological Report 2023. Stockholm: ECDC; 2024. Available from: https://www.ecdc.europa.eu/en/publications-data/antimicrobial-consumption-eueea-esac-net-annual-epidemiological-report-2023
  20. Rubinić I, Leung VH, Högberg LD, Monnet DL, Vlahović-Palčevski V, ESAC-Net study group. Measuring hospital antibiotic consumption in EU/EEA countries: comparison of different metrics, 2017 to 2021. Euro Surveill. 2024;29(46):2400317.  https://doi.org/10.2807/1560-7917.ES.2024.29.46.2400317  PMID: 39544143 
  21. Kern WV, Steib-Bauert M, Fellhauer M, Baumann J, Först G, Kramme E, et al. [Antibiotic prescribing trends in German acute care hospitals from 2012/13 through 2021/22]. Dtsch Med Wochenschr. 2025;150(3):e1-10. German. PMID: 39612945 
  22. Stenehjem E, Hyun DY, Septimus E, Yu KC, Meyer M, Raj D, et al. Antibiotic stewardship in small hospitals: barriers and potential solutions. Clin Infect Dis. 2017;65(4):691-6.  https://doi.org/10.1093/cid/cix407  PMID: 28472291 
  23. Mokrani D, Chommeloux J, Pineton de Chambrun M, Hékimian G, Luyt CE. Antibiotic stewardship in the ICU: time to shift into overdrive. Ann Intensive Care. 2023;13(1):39.  https://doi.org/10.1186/s13613-023-01134-9  PMID: 37148398 
  24. Benko R, Matuz M, Doro P, Viola R, Hajdu E, Monnet DL, et al. Hungarian hospital antibiotic consumption at the regional level, 1996-2005. Infection. 2009;37(2):133-7.  https://doi.org/10.1007/s15010-008-7468-6  PMID: 19169634 
  25. Aghdassi SJS, Gastmeier P, Behnke M, Hansen S, Kramer TS. Redundant anaerobic antimicrobial prescriptions in German acute care hospitals: data from a national point prevalence survey. Antibiotics (Basel). 2020;9(6):288. https://doi.org/10.3390/antibiotics9060288  PMID: 32481490 
  26. Menz BD, Charani E, Gordon DL, Leather AJM, Moonesinghe SR, Phillips CJ. Surgical antibiotic prophylaxis in an era of antibiotic resistance: common resistant bacteria and wider considerations for practice. Infect Drug Resist. 2021;14:5235-52.  https://doi.org/10.2147/IDR.S319780  PMID: 34908856 
  27. Schweickert B, Willrich N, Feig M, Schneider M, Behnke M, Peña Diaz LA, et al. Kinetic patterns of antibiotic consumption in German acute care hospitals from 2017 to 2023. Antibiotics (Basel). 2025;14(3):316.  https://doi.org/10.3390/antibiotics14030316  PMID: 40149126 
  28. Kern WV, Steib-Bauert M, Baumann J, Kramme E, Först G, de With K. Impact of the COVID-19 pandemic on inpatient antibiotic and antifungal drug prescribing volumes in Germany. Antibiotics (Basel). 2024;13(9):837.  https://doi.org/10.3390/antibiotics13090837  PMID: 39335010 
/content/10.2807/1560-7917.ES.2025.30.45.2500560
Loading

Data & Media loading...

Supplementary data

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error